Truist Financial Increases Sage Therapeutics (NASDAQ:SAGE) Price Target to $9.00
Sage Therapeutics (NASDAQ:SAGE – Get Free Report) had its price target lifted by Truist Financial from $8.00 to $9.00 in a report released on Tuesday,Benzinga reports. The firm presently has a “hold” rating on the biopharmaceutical company’s stock. Truist Financial’s price target suggests a potential downside of 1.42% from the company’s current price. A number […]
Sage Therapeutics (NASDAQ:SAGE – Get Free Report) had its price target lifted by Truist Financial from $8.00 to $9.00 in a report released on Tuesday,Benzinga reports. The firm presently has a “hold” rating on the biopharmaceutical company’s stock. Truist Financial’s price target suggests a potential downside of 1.42% from the company’s current price. A number […]
